Barry Canton, 10% Owner at Ginkgo Bioworks Holdings, Inc. (DNA), sold 112,950 shares at $1.77 ($210K) on 2023-08-10, disclosed to the SEC on 2023-08-11.
Scheduled sale ($210k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.04 | 37,650 | $77K | 36.6% |
| 2 | $1.77 | 37,650 | $67K | 31.7% |
| 3 | $1.77 | 37,650 | $67K | 31.7% |
| Total | $1.86 avg | 112,950 | $210K | 100% |
| Filing → |
| DNA | SELL | 2023-12-22 | $133K | — | Filing → |
| DNA | SELL | 2023-12-15 | $173K | — | Filing → |
| DNA | SELL | 2023-12-08 | $99K | — | Filing → |